Latest

Multiple Sclerosis

·November 15, 2020·4 min read

Promising Multiple Sclerosis Drug Could Worsen Disease

TEPP-46, a drug developed for the treatment of cancer and showed promise for the treatment of multiple sclerosis, could make MS symptoms worse, a new study reports. The drug appears to redirect inflammation away from the spinal cord and directly into the brain.

Featured Neurology Neuroscience

·November 6, 2020·4 min read

New Strategies for Restoring Myelin on Damaged Nerve Cells

Researchers have discovered a two-pronged approach to restore myelin on regenerated axons in a mouse model of optic nerve damage. The findings have positive implications for the treatment of multiple sclerosis.

Featured Neurology Neuroscience

·October 20, 2020·4 min read

Anti-Inflammatory Therapy Shows Promise in Slowing Progression of Multiple Sclerosis

A new intranasal delivery system shows promise in reducing neuroinflammation and slowing the progression of multiple sclerosis.

Featured Neurology Neuroscience

·October 16, 2020·3 min read

Study Explains the Process That Exacerbates Multiple Sclerosis

Recovery from multiple sclerosis-like symptoms in mice depends upon the ability for microglia to break down the remains of damaged cells.

Featured Neurology

·October 13, 2020·4 min read

New Therapy Improves Treatment for Multiple Sclerosis

By fusing a cytokine to a blood protein, researchers have developed a new therapy to help treat multiple sclerosis.

Featured Neurology

·October 7, 2020·3 min read

Simple Sugar Possible Therapy for Repairing Myelin in Multiple Sclerosis

N-acetylglucosamine, a simple sugar found in breast milk, promotes remyelination in mouse models of multiple sclerosis. The findings could have implications for treating multiple sclerosis in humans.

Featured Psychology

·September 18, 2020·3 min read

Immune System May Have Another Job, Combatting Depression

Gamma interferons, a type of immune cell that induces and modulates several immune system responses, may also play a role in preventing depression.

Featured Neurology Neuroscience

·September 14, 2020·6 min read

Pregnancy Can Delay Onset of Multiple Sclerosis Symptoms by Three Years

Women who have been pregnant were diagnosed with their first multiple sclerosis symptoms, on average, 3.3 years later than women with MS who had never become pregnant.

Featured Neurology

·August 26, 2020·4 min read

Tag Team Gut Bacteria Worsen Symptoms of Multiple Sclerosis

Specific combinations of microorganisms in the gut can worsen symptoms of multiple sclerosis in mouse models of the autoimmune disease.

Featured Genetics Neurology Open Neuroscience Articles

·August 24, 2020·5 min read

Mechanisms Identified to Restore Myelin Sheaths After Injury or in Multiple Sclerosis

eEF1a1 activated by acetylation prevents remyelination, but if the protein is deactivated by deacetylation, myelin sheaths can be rebuilt. The findings shed light on the process of remyelination and could provide avenues of treatment for multiple sclerosis, and other conditions associated with demyelination.

Featured Genetics Neurology

·August 12, 2020·4 min read

‘Reelin’ in a New Treatment for Multiple Sclerosis

Decreasing the amount of Reelin significantly protected against disease symptoms and promoted recovery in symptomatic animal models of multiple sclerosis. Reelin levels appear to correlate with MS severity and stages. Researchers report lowering levels of the protein could be a potential avenue of treatment for the autoimmune disorder.

Featured Neurology

·July 28, 2020·3 min read

Mental Fatigue of Multiple Sclerosis Linked to Inefficient Recruitment of Neural Resources

Those with MS allocate neural resources less effectively when faced with increased cognitive task demands, and this likely results in the increased mental fatigue those with the neurodegenerative disorder experience.